Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Choosing the right cash back credit card is crucial. Explore options to find the best card that fits your spending habits.
26,251 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Tesla looks different than it did a few years ago. This article explains why here's tesla stock before 2031 might off...
GE Vernova's stock slide today highlights how AI data center growth and sector volatility interact with broader marke...
Dynatrace stock plummeted today after earnings beat but soft guidance signaled a cautious path ahead. This article br...
A veteran fund manager challenges Wall Street's reliance on earnings when valuing AI plays, arguing that the E in P/E...
The S&P 500 reached a new record as Bitcoin faced renewed selling pressure. Analysts say the divide underscores a liq...
Beijing injects 300 billion yuan into short-term funding through an overnight reverse repo, a move traders are watchi...
Pfizer has reset its growth trajectory with big bets on Seagen and a future GLP-1 drug. This analysis breaks down wha...
Analysts stage a fresh look at Tesla’s 2027 price target, signaling a measured path ahead as product rollouts and cas...
A notable fund adds Masimo stock, signaling confidence in noninvasive monitoring tech. This analysis breaks down the ...
Divisadero Street Capital Management upped its stake in Dave (DAVE), fueling questions about a potential buying oppor...
Public feuds grab headlines and dollars alike. This article uses the Katie Price reignites Victoria moment to show pr...